No Data
No Data
12 Health Care Stocks Moving In Thursday's After-Market Session
Elevation Oncology Price Target Maintained With a $7.00/Share by Citizens Capital Markets
Elevation Oncology's Future in Jeopardy: Financing Challenges Threaten Product Development
Elevation Oncology Reports 2024 Financial Results and Progress
Express News | Stephens & Co. Reiterates Overweight on Elevation Oncology, Maintains $5 Price Target
Analysts Offer Insights on Healthcare Companies: Mind Medicine (MNMD), Elevation Oncology (ELEV) and Xeris Pharmaceuticals (XERS)